Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Hun Lee

Showing results (151-160 of 248) with videos related to

Pageof 25
Sort By:
Pharmacogenetics and Genomics|April 13, 2007
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancerSae-Won Han, Yoon Kyung Jeon, Kyung-Hun Lee, et al.
Plos One|December 17, 2015
Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal CancerYoojoo Lim, Sae-Won Han, Jeong Hee Yoon, et al.
Breast Cancer Research and Treatment|June 23, 2016
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancerKoung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
Frontiers in Oncology|February 9, 2023
Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physiciansSoo Yeon Baek, Kyung-Hun Lee, Sung-Bae Kim, et al.
The Korean Journal of Hepatology|April 9, 2010
[Validity and reliability of the nonalcoholic fatty liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors]Kyung Hun Lee, Sang Hoon Park, Yu Jin Kim, et al.
Journal of Psychosomatic Research|April 5, 2022
The longitudinal effects of chronotype on chemotherapy-induced nausea and vomiting in patients with breast cancer receiving neoadjuvant chemotherapySanghyup Jung, Kyung-Lak Son, Saim Jung, et al.
Cancer Chemotherapy and Pharmacology|April 11, 2015
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancerJin Won Kim, In Sil Choi, Yu Jung Kim, et al.
Breast Cancer Research : BCR|May 1, 2025
Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived modelsSoon-Chan Kim, Ga-Hye Kim, Jae-Hyeon Park, et al.
Journal of Breast Cancer|May 13, 2020
Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer PatientsYaewon Yang, Ahrum Min, Kyung-Hun Lee, et al.
BMC Cancer|July 23, 2016
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analysesYaewon Yang, Seock-Ah Im, Bhumsuk Keam, et al.
Pageof 25

Showing results (151-160 of 248) with videos related to

Sort By:
Pageof 25
Pharmacogenetics and Genomics|April 13, 2007
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancerSae-Won Han, Yoon Kyung Jeon, Kyung-Hun Lee, et al.
Plos One|December 17, 2015
Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal CancerYoojoo Lim, Sae-Won Han, Jeong Hee Yoon, et al.
Breast Cancer Research and Treatment|June 23, 2016
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancerKoung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
Frontiers in Oncology|February 9, 2023
Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physiciansSoo Yeon Baek, Kyung-Hun Lee, Sung-Bae Kim, et al.
The Korean Journal of Hepatology|April 9, 2010
[Validity and reliability of the nonalcoholic fatty liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors]Kyung Hun Lee, Sang Hoon Park, Yu Jin Kim, et al.
Journal of Psychosomatic Research|April 5, 2022
The longitudinal effects of chronotype on chemotherapy-induced nausea and vomiting in patients with breast cancer receiving neoadjuvant chemotherapySanghyup Jung, Kyung-Lak Son, Saim Jung, et al.
Cancer Chemotherapy and Pharmacology|April 11, 2015
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancerJin Won Kim, In Sil Choi, Yu Jung Kim, et al.
Breast Cancer Research : BCR|May 1, 2025
Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived modelsSoon-Chan Kim, Ga-Hye Kim, Jae-Hyeon Park, et al.
Journal of Breast Cancer|May 13, 2020
Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer PatientsYaewon Yang, Ahrum Min, Kyung-Hun Lee, et al.
BMC Cancer|July 23, 2016
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analysesYaewon Yang, Seock-Ah Im, Bhumsuk Keam, et al.
Pageof 25